<p>Exencial Wealth Advisors LLC 在最近向证券交易委员会提交的 13F 文件中披露，其在丹纳赫公司（NYSE:DHR - 免费报告）第二季度的持股增加了 56.1%。该机构投资者在本季度额外购买了 6,681 股后，持有该综合企业的 18,595 股股票。Exencial Wealth Advisors LLC 在丹纳赫的持股在最近一个季度末的价值为 3,673,000 美元。</p>
<ul>
<li>一项隐藏在明面上的人工智能投资：约翰逊控制公司分析</li>
</ul>
<p>其他几家对冲基金和机构投资者最近也增加或减少了在该公司的股份。GHP Investment Advisors Inc. 在第一季度将其在丹纳赫的股份增加了 396.0%。GHP Investment Advisors Inc. 目前持有 124 股该综合企业的股票，价值 25,000 美元，此前在该期间内又购买了 99 股。Sierra Ocean LLC 在第一季度将其在丹纳赫的股份增加了 116.9%。Sierra Ocean LLC 目前持有 141 股该综合企业的股票，价值 29,000 美元，此前在该期间内又购买了 76 股。Red Tortoise LLC 在第二季度将其在丹纳赫的股份增加了 175.0%。Red Tortoise LLC 目前持有 154 股该综合企业的股票，价值 30,000 美元，此前在该期间内又购买了 98 股。Smallwood Wealth Investment Management LLC 在第一季度购买了丹纳赫的新股份，价值约 31,000 美元。最后，Ramirez Asset Management Inc. 在第二季度购买了丹纳赫的新股份，价值约 40,000 美元。79.05% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>内部人士下注</h2>
<p>在相关消息中，董事 Teri List 于 8 月 22 日星期五出售了 2,778 股该股票。股票以平均价格 211.06 美元出售，总交易额为 586,324.68 美元。出售后，该董事在公司中持有 20,751 股，价值约 4,379,706.06 美元。这代表其持股减少了 11.81%。该交易在向 SEC 提交的文件中披露，相关文件可通过此超链接访问。内部人士持有公司 11.10% 的股票。</p>
<h2>华尔街分析师预测增长</h2>
<ul>
<li>3 只提供强大价值和稳定性的股票</li>
</ul>
<p>几位研究分析师对该公司发表了看法。Rothschild &amp; Co Redburn 在 10 月 8 日星期三的研究报告中重申了 “中性” 评级，并将丹纳赫的目标价下调至 220.00 美元（低于 245.00 美元）。德意志银行将丹纳赫的目标价从 235.00 美元上调至 250.00 美元，并在星期三的研究报告中给予该股票 “买入” 评级。Cowen 在星期三的研究报告中重申了对丹纳赫股票的 “买入” 评级。TD Cowen 在星期三的研究报告中将丹纳赫的目标价从 250.00 美元上调至 260.00 美元，并给予该公司 “买入” 评级。最后，Wall Street Zen 在 6 月 27 日星期五的研究报告中将丹纳赫的评级从 “持有” 上调至 “买入”。十七位研究分析师对该股票给予了 “买入” 评级，六位分析师给予了 “持有” 评级。根据 MarketBeat 的数据，丹纳赫目前的共识评级为 “适度买入”，共识目标价为 243.39 美元。</p>
<p><strong>阅读我们关于丹纳赫的最新研究报告</strong></p>
<h2>丹纳赫股票表现</h2>
<ul>
<li>安捷伦科技因 “永恒化学品” 打击而蓬勃发展</li>
</ul>
<p>NYSE:DHR 周四开盘价为 218.06 美元。该股票的 50 日移动平均线为 202.24 美元，200 日移动平均线为 197.73 美元。丹纳赫公司的 52 周低点为 171.00 美元，52 周高点为 260.88 美元。该公司的市值为 1561.4 亿美元，市盈率为 44.96，市盈增长比率为 3.20，贝塔值为 0.77。该公司的债务与股本比率为 0.32，速动比率为 1.22，流动比率为 1.62。</p>
<p>丹纳赫（NYSE:DHR - 获取免费报告）最近于 10 月 21 日星期二发布了季度财报。该综合企业报告本季度每股收益为 1.89 美元，超出市场共识预期的 1.72 美元，超出 0.17 美元。丹纳赫的股本回报率为 10.93%，净利润率为 14.44%。该公司本季度的收入为 60.5 亿美元，而分析师预期为 60 亿美元。在去年同期，该公司每股收益为 1.71 美元。丹纳赫的季度收入较去年同期增长了 4.4%。丹纳赫已将其 2025 财年的指引设定为每股收益 7.700-7.800 美元。平均而言，卖方分析师预计丹纳赫公司今年将发布每股收益 7.63 美元。</p>
<h2>丹纳赫宣布分红</h2>
<p>该公司最近还宣布了一项季度分红，将于 10 月 31 日星期五支付。9 月 26 日星期五的登记投资者将获得每股 0.32 美元的分红。这代表每年 1.28 美元的分红，收益率为 0.6%。除息日期为 9 月 26 日星期五。丹纳赫的分红支付比率目前为 27.23%。</p>
<h2>关于丹纳赫</h2>
<p>（免费报告）</p>
<p>丹纳赫公司在全球范围内设计、制造和销售专业、医疗、工业和商业产品及服务。生物技术部门提供生物处理技术、耗材和服务，以推进、加速和整合治疗药物的开发和生产；细胞系和细胞培养基开发服务；用于制造的细胞培养基、工艺液体和缓冲液；色谱树脂、过滤技术、无菌灌装；一次性硬件和耗材及服务，如完整制造套件的设计和安装；实验室过滤、分离和纯化；实验室规模的蛋白质纯化和分析工具；试剂、膜和服务；以及医疗过滤解决方案。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们认为比丹纳赫更好的股票</li>
<li>最佳 ESG 股票：11 只最佳 ESG 投资股票</li>
<li>阿彻最近的一系列胜利标志着一个新的增长阶段</li>
<li>零售股票投资解析</li>
<li>3 只在基本面改善中推动回购的关键股票</li>
<li>股票评级和推荐：理解分析师评级</li>
<li>选择股票的最佳人工智能，按表现排名</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在丹纳赫吗？</h2>
<p>在你考虑丹纳赫之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而丹纳赫并不在名单上。</p>
<p>虽然丹纳赫目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

丹纳赫

<p>Exencial Wealth Advisors LLC 在第二季度将其在丹纳赫公司（NYSE:DHR）的股份增加了 56.1%，目前持有 18,595 股，价值 367 万美元。其他机构投资者也增加了他们的持股。丹纳赫股票的共识评级为 “适度买入”，目标价格为 243.39 美元。该公司报告了第三季度每股收益为 1.89 美元，超出预期，收入为 60.5 亿美元，同比增长 4.4%。宣布了季度股息，将于 10 月 31 日支付</p>

<p>Exencial Wealth Advisors LLC increased its position in Danaher Corporation (NYSE:DHR - Free Report) by 56.1% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,595 shares of the conglomerate's stock after acquiring an additional 6,681 shares during the quarter. Exencial Wealth Advisors LLC's holdings in Danaher were worth $3,673,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Exencial Wealth Advisors LLC 在最近向证券交易委员会提交的 13F 文件中披露，其在丹纳赫公司（NYSE:DHR - 免费报告）第二季度的持股增加了 56.1%。该机构投资者在本季度额外购买了 6,681 股后，持有该综合企业的 18,595 股股票。Exencial Wealth Advisors LLC 在丹纳赫的持股在最近一个季度末的价值为 3,673,000 美元。</p>
</div><ul>
<li>An AI Play Hiding in Plain Sight: A Look at Johnson Controls</li>
</ul>
<div class="lb-trans"><ul>
<li>一项隐藏在明面上的人工智能投资：约翰逊控制公司分析</li>
</ul>
</div><p>Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. GHP Investment Advisors Inc. boosted its stake in Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after purchasing an additional 99 shares during the period. Sierra Ocean LLC boosted its stake in Danaher by 116.9% in the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after purchasing an additional 76 shares during the period. Red Tortoise LLC boosted its stake in Danaher by 175.0% in the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate's stock worth $30,000 after purchasing an additional 98 shares during the period. Smallwood Wealth Investment Management LLC bought a new position in Danaher in the 1st quarter worth approximately $31,000. Finally, Ramirez Asset Management Inc. bought a new position in Danaher in the 2nd quarter worth approximately $40,000. 79.05% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他几家对冲基金和机构投资者最近也增加或减少了在该公司的股份。GHP Investment Advisors Inc. 在第一季度将其在丹纳赫的股份增加了 396.0%。GHP Investment Advisors Inc. 目前持有 124 股该综合企业的股票，价值 25,000 美元，此前在该期间内又购买了 99 股。Sierra Ocean LLC 在第一季度将其在丹纳赫的股份增加了 116.9%。Sierra Ocean LLC 目前持有 141 股该综合企业的股票，价值 29,000 美元，此前在该期间内又购买了 76 股。Red Tortoise LLC 在第二季度将其在丹纳赫的股份增加了 175.0%。Red Tortoise LLC 目前持有 154 股该综合企业的股票，价值 30,000 美元，此前在该期间内又购买了 98 股。Smallwood Wealth Investment Management LLC 在第一季度购买了丹纳赫的新股份，价值约 31,000 美元。最后，Ramirez Asset Management Inc. 在第二季度购买了丹纳赫的新股份，价值约 40,000 美元。79.05% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><p>In related news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 11.10% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，董事 Teri List 于 8 月 22 日星期五出售了 2,778 股该股票。股票以平均价格 211.06 美元出售，总交易额为 586,324.68 美元。出售后，该董事在公司中持有 20,751 股，价值约 4,379,706.06 美元。这代表其持股减少了 11.81%。该交易在向 SEC 提交的文件中披露，相关文件可通过此超链接访问。内部人士持有公司 11.10% 的股票。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><ul>
<li>3 Stocks Offering Strong Value and Stability</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只提供强大价值和稳定性的股票</li>
</ul>
</div><p>Several research analysts have weighed in on the company. Rothschild &amp; Co Redburn restated a &#34;neutral&#34; rating and issued a $220.00 price target (down from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft upped their price target on Danaher from $235.00 to $250.00 and gave the stock a &#34;buy&#34; rating in a research note on Wednesday. Cowen reiterated a &#34;buy&#34; rating on shares of Danaher in a research report on Wednesday. TD Cowen increased their target price on Danaher from $250.00 to $260.00 and gave the company a &#34;buy&#34; rating in a research report on Wednesday. Finally, Wall Street Zen upgraded Danaher from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research report on Friday, June 27th. Seventeen research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, Danaher currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $243.39.</p>
<div class="lb-trans"><p>几位研究分析师对该公司发表了看法。Rothschild &amp; Co Redburn 在 10 月 8 日星期三的研究报告中重申了 “中性” 评级，并将丹纳赫的目标价下调至 220.00 美元（低于 245.00 美元）。德意志银行将丹纳赫的目标价从 235.00 美元上调至 250.00 美元，并在星期三的研究报告中给予该股票 “买入” 评级。Cowen 在星期三的研究报告中重申了对丹纳赫股票的 “买入” 评级。TD Cowen 在星期三的研究报告中将丹纳赫的目标价从 250.00 美元上调至 260.00 美元，并给予该公司 “买入” 评级。最后，Wall Street Zen 在 6 月 27 日星期五的研究报告中将丹纳赫的评级从 “持有” 上调至 “买入”。十七位研究分析师对该股票给予了 “买入” 评级，六位分析师给予了 “持有” 评级。根据 MarketBeat 的数据，丹纳赫目前的共识评级为 “适度买入”，共识目标价为 243.39 美元。</p>
</div><p><strong>Read Our Latest Research Report on Danaher</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于丹纳赫的最新研究报告</strong></p>
</div><h2>Danaher Stock Performance</h2>
<div class="lb-trans"><h2>丹纳赫股票表现</h2>
</div><ul>
<li>Agilent Technologies Thrives From the Forever Chemicals Crackdown</li>
</ul>
<div class="lb-trans"><ul>
<li>安捷伦科技因 “永恒化学品” 打击而蓬勃发展</li>
</ul>
</div><p>NYSE:DHR opened at $218.06 on Thursday. The stock's fifty day moving average is $202.24 and its 200 day moving average is $197.73. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $260.88. The firm has a market capitalization of $156.14 billion, a PE ratio of 44.96, a PEG ratio of 3.20 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62.</p>
<div class="lb-trans"><p>NYSE:DHR 周四开盘价为 218.06 美元。该股票的 50 日移动平均线为 202.24 美元，200 日移动平均线为 197.73 美元。丹纳赫公司的 52 周低点为 171.00 美元，52 周高点为 260.88 美元。该公司的市值为 1561.4 亿美元，市盈率为 44.96，市盈增长比率为 3.20，贝塔值为 0.77。该公司的债务与股本比率为 0.32，速动比率为 1.22，流动比率为 1.62。</p>
</div><p>Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.93% and a net margin of 14.44%.The company had revenue of $6.05 billion for the quarter, compared to analyst estimates of $6 billion. During the same quarter in the prior year, the firm posted $1.71 EPS. Danaher's quarterly revenue was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, sell-side analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current year.</p>
<div class="lb-trans"><p>丹纳赫（NYSE:DHR - 获取免费报告）最近于 10 月 21 日星期二发布了季度财报。该综合企业报告本季度每股收益为 1.89 美元，超出市场共识预期的 1.72 美元，超出 0.17 美元。丹纳赫的股本回报率为 10.93%，净利润率为 14.44%。该公司本季度的收入为 60.5 亿美元，而分析师预期为 60 亿美元。在去年同期，该公司每股收益为 1.71 美元。丹纳赫的季度收入较去年同期增长了 4.4%。丹纳赫已将其 2025 财年的指引设定为每股收益 7.700-7.800 美元。平均而言，卖方分析师预计丹纳赫公司今年将发布每股收益 7.63 美元。</p>
</div><h2>Danaher Announces Dividend</h2>
<div class="lb-trans"><h2>丹纳赫宣布分红</h2>
</div><p>The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher's dividend payout ratio is presently 27.23%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度分红，将于 10 月 31 日星期五支付。9 月 26 日星期五的登记投资者将获得每股 0.32 美元的分红。这代表每年 1.28 美元的分红，收益率为 0.6%。除息日期为 9 月 26 日星期五。丹纳赫的分红支付比率目前为 27.23%。</p>
</div><h2>About Danaher</h2>
<div class="lb-trans"><h2>关于丹纳赫</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.</p>
<div class="lb-trans"><p>丹纳赫公司在全球范围内设计、制造和销售专业、医疗、工业和商业产品及服务。生物技术部门提供生物处理技术、耗材和服务，以推进、加速和整合治疗药物的开发和生产；细胞系和细胞培养基开发服务；用于制造的细胞培养基、工艺液体和缓冲液；色谱树脂、过滤技术、无菌灌装；一次性硬件和耗材及服务，如完整制造套件的设计和安装；实验室过滤、分离和纯化；实验室规模的蛋白质纯化和分析工具；试剂、膜和服务；以及医疗过滤解决方案。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Danaher</li>
<li>Best ESG Stocks: 11 Best Stocks for ESG Investing</li>
<li>Archer’s Recent String of Victories Signals a New Phase of Growth</li>
<li>Retail Stocks Investing, Explained</li>
<li>3 Key Stocks Boosting Buybacks Amid Improving Fundamentals</li>
<li>Stock Ratings and Recommendations: Understanding Analyst Ratings</li>
<li>The Best AI for Picking Stocks, Ranked by Performance</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比丹纳赫更好的股票</li>
<li>最佳 ESG 股票：11 只最佳 ESG 投资股票</li>
<li>阿彻最近的一系列胜利标志着一个新的增长阶段</li>
<li>零售股票投资解析</li>
<li>3 只在基本面改善中推动回购的关键股票</li>
<li>股票评级和推荐：理解分析师评级</li>
<li>选择股票的最佳人工智能，按表现排名</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=DHR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Danaher Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在丹纳赫吗？</h2>
</div><p>Before you consider Danaher, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑丹纳赫之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而丹纳赫并不在名单上。</p>
</div><p>While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然丹纳赫目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Exencial Wealth Advisors LLC 增加了其在丹纳赫公司 $DHR 的持股量